West Pharmaceutical Services has announced the availability of the 1-3mL NovaPure plunger, a component for pre-filled delivery systems
1-3mL NovaPure plunger
West said that the plunger is designed to reduce particulate, ensure consistency of delivery and fit the changing needs of higher-volume injectable drug delivery systems.
This new offering adds to West’s current portfolio of NovaPure products, which includes the 1mL long NovaPure plunger and 13mm and 20mm NovaPure lyo and serum stoppers.
Karen Flynn, senior vice president and chief commercial officer, West, said: “Over the past several years, the pharmaceutical industry has seen a steady rise in new biologic drugs coming onto the market for the treatment of chronic conditions, and these sophisticated therapies often have very specialised containment needs.
“We are proud to introduce a packaging solution that can help protect the safety, efficacy and purity of these therapies.”
West said its 1-3mL NovaPure plungers have a breakloose and glide force profile which makes the 1-3mL NovaPure plungers ideal to deliver consistent functional performance for auto-injector applications across various injection volumes, including as part of increasingly common 2.25mL injectable drug delivery systems.
Flynn said: “West is committed to helping its customers address both current and future healthcare challenges with a deep understanding of the complex needs of biologics.
“We believe the new 1-3mL NovaPure plunger, backed by a body of scientific data and design history file, provides the performance and quality required to safely and effectively deliver these advanced drug products, helping our customers bring high-quality therapeutics to market more easily.”
Additionally, as more biologics are being self-administered by patients at home, ease-of-use and convenience are increasingly important. By delivering a more consistent injection rate, West said its 1-3 mL NovaPure plungers can help ensure patients receive accurate dosing of their treatment regimen.